2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines
Retrieved on:
Sonntag, Juni 19, 2022
RNA, National Institutes of Health, University, Animal, Science, Lipid, Infection, Protein, Health, Deoxyribonucleoside, BioNTech, Nanoparticle, Life, Patent, COVID-19, Vaccine, Inflammation, Nobel Prize, Death, Technology, Antigen, DNA, Pfizer–BioNTech COVID-19 vaccine, Tang Prize, Immune system, LNP, Ribose, Ribonucleoside, Cell, NIH, Doctor of Philosophy, Civilization, Climate change, FDA, World, Nucleoside, Virus, HIV, Rule of law, Coronavirus, Physics, Multimedia, COVID, RNA transfection, Antibody, Zika virus, Research, World Health Organization's response to the COVID-19 pandemic, Cancer, Toll-like receptor, LN, Severe acute respiratory syndrome coronavirus 2, Paganini Competition, Deoxyribose, Sustainable development, Membrane, National, Pharmaceutical industry, Moderna, Sinology, Nobel
After much waiting, names of the latest winners were finally announced at ten (GMT+8) in the morning of June 19.
Key Points:
- After much waiting, names of the latest winners were finally announced at ten (GMT+8) in the morning of June 19.
- Fortunately, it took Pfizer/BioNTech and Moderna less than 12 months to successfully develop vaccines against SARS-CoV-2.
- While Dr. Kariko and Dr. Weissman found a way to reduce the immunogenicityiof mRNA, Dr. Cullis is credited with designing lipid nanoparticles for the delivery of mRNA vaccines.
- These mRNA molecules are encapsulated in lipid nanoparticles and delivered effectively into the cells.